2013 Q1/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +1 Siegfried AG
8.6
2 -1 NovImmune
8.2
3 +15 Vifor (International) Ltd.
8.1
4 +0 Piramal Healthcare
8.0
5 -2 Newron Suisse SA
7.9
6 -1 GenKyoTex SA
7.6
7 -1 4-Antibody AG
7.6
8 -1 Eisai (company)
7.6
9 +0 Kuros Biosurgery AG
7.3
10 +0 LEO Pharmaceutical Products Sarath Ltd.
7.1
11 +10 Acino Holding AG
7.1
12 +0 Biotecnol
7.0
13 +21 Aptalis
6.9
14 -2 Actelion Ltd.
6.8
15 +0 Multipharma
6.8
16 -1 Renovo
6.8
17 -4 Max Zeller Söhne AG
6.7
18 +1 Galenica Ltd.
6.4
19 -2 Sandoz Pharmaceuticals AG
6.3
20 +9 Arpida AG
6.3
21 -7 Eli Lilly Schweiz
6.3
22 +13 Neurotune
6.2
23 -3 Intercytex
6.2
24 -8 Helvepharm AG
6.2
25 -2 Astellas Pharma AG
6.2
26 +10 Nectar Lifesciences
6.1
27 -3 Virbac Schweiz AG
6.1
28 +2 Evolva SA
6.0
29 +9 Kyowa Hakko
6.0
30 -3 Cilag AG
6.0
31 +1 Sanofi-Pasteur MSD AG
5.9
32 +23 Lundbeck (Schweiz) AG
5.9
33 +13 Servier Laboratories
5.9
34 +13 Auris Medical AG
5.9
35 +15 Actavis
5.8
36 +7 Addex Pharmaceuticals
5.8
37 +0 Dr. Wild & Co. AG
5.8
38 -5 IBSA
5.6
39 -8 Nycomed Pharma AG
5.6
40 +18 Ortho-McNeil Pharmaceutical
5.6
41 -1 Debiopharm S.A.
5.5
42 -31 Wockhardt
5.5
43 +6 Medinova AG
5.5
44 -5 Octapharma AG
5.5
45 +7 IMULAN BioTherapeutics, LLC
5.4
46 +74 AmVac AG
5.4
47 -3 Teva Pharma AG
5.4
48 +0 Biogen Idec International GmbH
5.4
49 -41 Gebro Pharma AG
5.4
50 +4 Salmon Pharma GmbH
5.4


Changes in rank are compared to 2012 Q4/Global Life Sciences. Since then, 8 sites entered the survey, 7 sites left the survey and 49 sites could not be included in the rankings (6 fewer since last time). Build your own. Report statistics.